Blood marker may predict DVT complications
NCT ID NCT05789108
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 178 patients hospitalized with a first-time deep vein thrombosis (DVT) in the leg. Researchers will take blood samples and perform ultrasounds to see if certain markers, like suPAR, can predict long-term complications such as post-thrombotic syndrome. The goal is to better understand who is at risk and improve follow-up care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify DVT patients at higher risk for long-term complications, leading to better follow-up care.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a clear link between the blood markers and complications, and results may not apply to all DVT patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DVT OF LEGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen University Hospital Hvidovre
RECRUITINGHvidovre, Copenhagen, 2650, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••